ethylphenylhydantoin has been researched along with hydantoins in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (88.89) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacMillan, SF; Raisys, VA; Zebelman, AM | 1 |
| Bircher, J; Küpfer, A; Preisig, R | 1 |
| Pezeshk, A; Pezeshk, V | 1 |
| Diwan, BA; Hu, H; Lubet, RA; Nims, RW; Rice, JM; Ward, JM | 1 |
| Alpin, RS; Day, PA; Hall, IH; Maguire, JH; Wong, OT | 1 |
| Inaba, T | 1 |
| Inaba, T; Jurima, M; Kalow, W | 1 |
| Desai, BT; Kupferberg, HJ; Newmark, ME; Penry, JK; Porter, RJ; Theodore, WH; Yonekawa, WD | 1 |
| Küpfer, A; Preisig, R | 1 |
| Branch, RA; McAllister, CB; Sweetman, BJ; Wedlund, PJ; Wilkinson, GR | 1 |
| Branch, RA; Küpfer, A; Patwardhan, R; Preisig, R; Schenker, S; Ward, S | 1 |
| Harbison, RD; Küpfer, A; Lawson, JA; Wells, PG | 1 |
| Roeda, D; Westera, G | 1 |
| BUTLER, TC | 2 |
| BUTLER, TC; WADDELL, WJ | 1 |
| CRAVIOTTO, C | 1 |
| Jones, JP; Kneller, MB; Rettie, AE; Rock, DA; Suzuki, H; Trager, WF | 1 |
1 review(s) available for ethylphenylhydantoin and hydantoins
| Article | Year |
|---|---|
Genetic polymorphism of mephenytoin metabolism.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chemical Phenomena; Chemistry; China; Cytochrome P-450 CYP2C19; Debrisoquin; Dogs; Ethnicity; Humans; Hydantoins; Hydroxylation; Japan; Kinetics; Liver; Mephenytoin; Mephobarbital; Mice; Mixed Function Oxygenases; Ontario; Phenotype; Polymorphism, Genetic; Sparteine; Tennessee; White People | 1986 |
17 other study(ies) available for ethylphenylhydantoin and hydantoins
| Article | Year |
|---|---|
Gas-chromatographic determination of mephenytoin and desmethylmephenytoin, after off-column alkylation.
Topics: Alkylation; Chromatography, Gas; Humans; Hydantoins; Mephenytoin | 1979 |
Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog.
Topics: Animals; Bile; Chromatography, Gas; Dogs; Female; Hydantoins; Kinetics; Mephenytoin; Stereoisomerism | 1977 |
Drug-metal interactions: spectroscopic studies of copper hydantoin complexes.
Topics: Copper; Crystallization; Electron Spin Resonance Spectroscopy; Hydantoins; Mephenytoin; Molecular Structure; Phenytoin; Pyridines; Spectrophotometry, Infrared | 1991 |
P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
Topics: Animals; Barbital; Barbiturates; Body Weight; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Enzyme Induction; Hydantoins; Liver; Liver Neoplasms, Experimental; Male; Mephenytoin; Organ Size; Phenobarbital; Rats; Rats, Inbred F344; Thyroid Neoplasms | 1988 |
A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodents.
Topics: Administration, Oral; Animals; Cholesterol; Feces; Hydantoins; Hypolipidemic Agents; Injections, Intraperitoneal; Intestine, Small; Isomerism; Lipid Metabolism; Lipoproteins; Liver; Male; Mephenytoin; Mice; Rats; Rats, Inbred Strains; Reference Values; Structure-Activity Relationship; Triglycerides | 1987 |
Family studies of mephenytoin hydroxylation deficiency.
Topics: Adolescent; Adult; Female; Genes, Recessive; Humans; Hydantoins; Hydroxylation; Male; Mephenytoin; Middle Aged; Pedigree; Phenotype | 1986 |
Disposition of mephenytoin and its metabolite, nirvanol, in epileptic patients.
Topics: Adolescent; Adult; Epilepsies, Partial; Female; Humans; Hydantoins; Male; Mephenytoin | 1984 |
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Topics: Adult; Debrisoquin; Female; Humans; Hydantoins; Hydroxylation; Male; Mephenytoin; Phenotype; Polymorphism, Genetic | 1984 |
Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
Topics: Anticonvulsants; Chromatography, Gas; Half-Life; Humans; Hydantoins; Mephenytoin; Stereoisomerism | 1984 |
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
Topics: Adolescent; Adult; Anticonvulsants; Half-Life; Humans; Hydantoins; Male; Mephenytoin; Stereoisomerism; Time Factors | 1984 |
Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
Topics: Animals; Embryo, Mammalian; Female; Fetus; Hydantoins; Mephenytoin; Mice; Mice, Inbred ICR; Pregnancy; Stereoisomerism | 1982 |
The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturates.
Topics: Anticonvulsants; Barbital; Barbiturates; Carbon Radioisotopes; Hydantoins; Isotope Labeling; Mephenytoin; Phenobarbital; Phenytoin | 1981 |
Quantitative studies of the physiological disposition of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and 5-ethyl-5-phenyl hydantoin (nirvanol).
Topics: Anticonvulsants; Blood; Humans; Hydantoins; Imidazoles; Mephenytoin | 1953 |
A pharmacological comparison of the optical isomers of 5-ethyl-5-phenyl hydantoin (nirvanol) and of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin).
Topics: Anticonvulsants; Hydantoins; Imidazoles; Mephenytoin | 1954 |
The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
Topics: Anticonvulsants; Hydantoins; Imidazoles; Mephenytoin | 1956 |
[Experimental ophthalmopathic syndrome in guinea pigs caused by prolonged administration of 3-methyl-5-ethylphenylhydantoin].
Topics: Animals; Cataract; Eye Diseases; Guinea Pigs; Hydantoins; Keratitis; Mephenytoin | 1961 |
Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors.
Topics: Aryl Hydrocarbon Hydroxylases; Barbiturates; Binding Sites; Computer Simulation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Design; Enzyme Activation; Hydantoins; Mephenytoin; Mixed Function Oxygenases; Models, Chemical; Models, Molecular; Phenobarbital; Phenytoin; Protein Binding | 2004 |